Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Vaccinia virus expression vector for selective replication in a tumor cell and introduction of exogenous nucleotide sequence into a tumor cell

Vaccinia virus expression vector for selective replication in a tumor cell and introduction of exogenous nucleotide sequence into a tumor cell

US Patent 8506947 · Granted Aug 13, 2013

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Oncolytic virus therapy2025
Virus-based expression vectors and uses thereof2021
Intergenic sites between conserved genes in the genome of modified vaccinia anka2019
Recombinant modified vaccinia ankara (MVA) vaccinia virus containing restructure2018
Monoclonal antibodies against orthopoxviruses2017
Recombinant MVA viruses expressing clade A/G, clade B, and clade C modified HIV 2016
Compositions and methods for generating an immune response2016
Modified vaccinia Ankara (MVA) virus recombinants comprising heterologous coding2015
Recombinant modified vaccinia ankara (MVA) vaccinia virus containing restructure2015
Monoclonal antibodies against Orthopoxviruses2015
MVA expressing modified HIV envelope, gag, and pol genes2014
Monoclonal antibodies against orthopoxviruses2013